IASLC Global Survey on Biomarker Testing in Lung Cancer – 2024 Update | IASLC
Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.
Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.
Silke Gillessen joins Brian and Tom to give a preview of this year’s ASCO annual meeting, including presentations to look out for on the prostate,…
ASTRO President-elect Sameer Keole, MD, FASTRO, encourages members to think of how they can volunteer for the field by serving on an ASTRO committee or…
A new study has found the risk of cervical precancer 8 years after a negative HPV screening result was comparable to the risk at 3…
Decades of research has dramatically changed cancer care, with more breakthrough treatments on the way thanks to clinical trials that pair patients with oncology experts.
Two concurrent 2-by-2 factorial design studies revealed which outreach strategies resulted in higher mammogram completion rates.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
AbstractBackground. This study was designed to identify common genetic susceptibility and shared genetic variants associated with acute radiation-induced t
Roswell Park Comprehensive Cancer Center earned top score of 100 on Human Rights Campaign Foundation survey.
Joyce F. Liu, MD, MPH, provides insights on WEE1 which has emerged as a potentially targetable pathway in high-grade serous ovarian cancer.
In a two-part commentary, Dr. Ke-Neng Chen discusses how surgeons must adjust in light of recent clinical trials, beginning with a discussion of the challenges…